James V. Lavilla

Mining of NovelHuman DPP-IV-Targeting Tripeptidesthrough Multicomputational Screening and In Vitro Validation for DiabetesTherapy

Abstract Inhibition of human dipeptidyl peptidase IV (hDPP-IV) is considered an effective strategy in the management of type 2 diabetes (T2D). However, the lack of high-throughput screening approaches and the high cost of experimental evaluation have limited the discovery of pept...